Provider and Patient Correlates of Provider Decisions to Recommend HCV Treatment to HIV Co-Infected Patients
Published in: Journal of the International Association of Physicians in AIDS Care, v. 11, no. 4, July/Aug. 2012, p. 245-251
Posted on RAND.org on January 01, 2012
Read MoreAccess further information on this document at Journal of the International Association of Physicians in AIDS Care
This article was published outside of RAND. The full text of the article can be found at the link above.
Despite low uptake of hepatitis C virus (HCV) treatment among HIV co-infected patients, few studies have examined the factors that contribute to provider decisions to recommend treatment. Surveys of 173 co-infected patients and their primary care providers, as well as patient chart data, were collected at 3 HIV clinics in Los Angeles; 73% of the patients had any history of being recommended HCV treatment. Multivariate predictors of being offered treatment included being Caucasian, greater HCV knowledge, receiving depression treatment if depressed, and one's provider having a lower weekly patient load and more years working at the study site. These findings suggest that provider decisions to recommend HCV treatment are influenced by patient factors including race and psychosocial treatment readiness, as well as characteristics of their own practice and treatment philosophy. With changes to HCV treatment soon to emerge, further evaluation of factors influencing treatment decisions is needed to improve HCV treatment uptake.